Merck Sharp & Dohme B.V. based in Haarlem, NL has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2024-07-11

US20240226082A1

Human necessities

COMBINATION THERAPIES FOR TREATING CANCER

#2 | 2020-09-17 ✅ Patent 12,156,872 granted on 2024-12-03

US20200289493A1

Human necessities

Combination therapies for treating cancer

#3 | 2020-09-17 ✅ Patent 11,077,050 granted on 2021-08-03

US20200289406A1

Human necessities

Formulation for parenteral administration

#4 | 2019-09-12 ✅ Patent 10,934,296 granted on 2021-03-02

US20190276456A1

Chemistry; metallurgy

4-imidazopyridazin-1-yl-benzamides as Btk inhibitors

#5 | 2019-08-01 ✅ Patent 11,051,508 granted on 2021-07-06

US20190230917A1

Human necessities

Apparatus and method for preserving mucosa

#6 | 2019-01-03 ✅ Patent 10,821,277 granted on 2020-11-03

US20190001111A1

Human necessities

Kit for and method of assembling an applicator for inserting an implant

#7 | 2019-01-03 ✅ Patent 11,040,184 granted on 2021-06-22

US20190001110A1

Human necessities

Kit for and method of assembling an applicator for inserting an implant

#8 | 2018-08-30 ✅ Patent 10,918,515 granted on 2021-02-16

US20180243125A1

Human necessities

Vaginal ring applicator

#9 | 2018-06-28 ✅ Patent 10,239,883 granted on 2019-03-26

US20180179212A1

Chemistry; metallurgy

4-imidazopyridazin-1-yl-benzamides as BTK inhibitors

#10 | 2017-11-30 ✅ Patent 9,884,043 granted on 2018-02-06

US20170340610A1

Human necessities

RORgammaT inhibitors

#11 | 2017-05-18 ✅ Patent 9,925,200 granted on 2018-03-27

US20170136033A1

Human necessities

Stable formulations of testosterone undecanoate

#12 | 2017-01-12 ✅ Patent 9,718,828 granted on 2017-08-01

US20170008899A1

Chemistry; metallurgy

BTK Inhibitors

#13 | 2016-06-09 ✅ Patent 9,790,226 granted on 2017-10-17

US20160159810A1

Chemistry; metallurgy

4-imidazopyridazin-1-yl-benzamides and 4-imidazotriazin-1-yl-benzamides as BtK inhibitors

#14 | 2016-06-02 ✅ Patent 9,758,524 granted on 2017-09-12

US20160151364A1

Human necessities

4-imidazopyridazin-1-yl-benzamides as Btk inhibitors

#15 | 2016-05-12 ✅ Patent 9,540,361 granted on 2017-01-10

US20160130262A1

Chemistry; metallurgy

N-substituted azetidine derivatives

#16 | 2015-11-19 ✅ Patent 10,155,259 granted on 2018-12-18

US20150329545A1

Chemistry; metallurgy

FSH receptor antagonists

#17 | 2015-10-22 ✅ Patent 9,603,838 granted on 2017-03-28

US20150297566A1

Human necessities

RORgammaT inhibitors

#18 | 2015-01-29 ✅ Patent 9,464,108 granted on 2016-10-11

US20150031875A1

Chemistry; metallurgy

Combined synthesis route for desogestrel and etonogestrel

#19 | 2014-09-25 ✅ Patent 9,102,676 granted on 2015-08-11

US20140288109A1

Chemistry; metallurgy

MK2 inhibitors

#20 | 2014-06-05 ✅ Patent 9,290,504 granted on 2016-03-22

US20140155385A1

Chemistry; metallurgy

4-imidazopyridazin-1-yl-benzamides and 4-imidazotriazin-1-yl-benzamides as Btk inhibitors

#21 | 2014-02-06 ✅ Patent 9,095,583 granted on 2015-08-04

US20140038942A1

Human necessities

RORgammaT inhibitors

#22 | 2013-10-10 ✅ Patent 8,808,744 granted on 2014-08-19

US20130266632A1

Human necessities

Drug delivery system based on polyethylene vinylacetate copolymers

#23 | 2013-05-09 ✅ Patent 8,900,615 granted on 2014-12-02

US20130115265A1

Human necessities

Drug delivery system

#24 | 2013-03-28 ✅ Patent 8,858,977 granted on 2014-10-14

US20130078286A1

Human necessities

Drug delivery system

#25 | 2013-01-24 ✅ Patent 8,637,551 granted on 2014-01-28

US20130023566A1

Chemistry; metallurgy

2-(1,2-benzisoxazol-3-yl)benzylamine derivatives

#26 | 2012-12-06 ✅ Patent 8,658,794 granted on 2014-02-25

US20120309966A1

Chemistry; metallurgy

8-methyl-1-phenyl-imidazol[1,5-a]pyrazine compounds as Lck inhibitors and uses thereof

#27 | 2012-11-08 ✅ Patent 9,115,126 granted on 2015-08-25

US20120283239A1

Chemistry; metallurgy

1H-[1,2,3]triazolo[4,5-c]pyridine-4-carbonitrile derivatives

#28 | 2012-09-27 ✅ Patent 8,772,286 granted on 2014-07-08

US20120245175A1

Chemistry; metallurgy

MK2 inhibitors

#29 | 2012-09-27 ✅ Patent 8,445,450 granted on 2013-05-21

US20120245109A1

Human necessities

Antithrombotic dual inhibitors comprising a biotin residue

#30 | 2012-09-20 ✅ Patent 9,108,939 granted on 2015-08-18

US20120238574A1

Chemistry; metallurgy

(1, 1, 1,3,3,3-hexafluoro-2 hydroxypropan-2-yl) phenyl derivative, pharmaceutical compositions thereof and their use for the treatment of atherosclerosis

#31 | 2012-09-13 ✅ Patent 8,729,274 granted on 2014-05-20